language_icon
EN
HI

Balaxi Pharmaceuticals Share price

BALAXI

27.46

0.18 (0.66%)
Last updated on 22 Apr, 2026 | 15:31 IST
Today's High

28.63

Today's Low

27.15

52 Week Low

15.20

52 Week High

67.19

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Balaxi Pharmaceuticals Chart

Balaxi Pharmaceuticals Share Key Metrics

Volume
75264.00
Market Cap
151.60 CR
LTQ@LTP
400@27.46
ATP
27.84
Var Margin
100 %
Circuit Range
25.92-28.64
Delivery %
0 %
Value
20.95 L
ASM/GSM
No
Market Lot
1

Summary

Balaxi Pharmaceuticals share price stands at ₹27.46 at 22 Apr, 2026 | 15:31. The stock Balaxi Pharmaceuticals intraday movement has stayed between ₹27.15 and ₹28.63, while on a 52-week basis it has fluctuated from ₹15.20 to ₹67.19.
In terms of trading activity, Balaxi Pharmaceuticals has recorded a volume of 75264 shares. The Balaxi Pharmaceuticals has a market cap of ₹55207500. The stock’s Average Traded Price (ATP) stands at ₹2784, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 400, 2746.
The Balaxi Pharmaceuticals operates within a circuit range of ₹25.92-28.64 – ₹25.92-28.64, with a Value of ₹20.95 L. The Delivery Percentage for the day is 0%. Additionally, Balaxi Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Balaxi Pharmaceuticals Fundamentals

View More
P/E Ratio

15.95

P/B Ratio

0.63

Div. Yield

0

Sector P/E

42.19

Sector P/B

2.11

Sec. Div. Yield

80.52

Balaxi Pharmaceuticals Resistance and Support

Pivot 27.32

Resistance

First Resistance

27.97

Second Resistance

28.65

Third Resistance

29.3

Support

First Support

26.64

Second Support

25.99

Third Support

25.31

Balaxi Pharmaceuticals Shareholding Pattern

View More
  • 2017-18
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

65.99%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

2.56%

Retail

31.45%

Others

0%

Total Promoters
MAR '26
65.99%

Balaxi Pharmaceuticals Corporate Actions

DateAgenda
No Data Found

Balaxi Pharmaceuticals News

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals' promoter group declared no direct or indirect encumbrance on shares for the financial year ended March 31, 2026. This confirms compliance with SEBI (Substantial Acquisition of Shares And Takeovers) Regulations, 2011.
Apr 10 2026 11:04:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals clarifies that recent significant stock price movement is purely market-driven. The company states there is no undisclosed material information or announcement impacting its price or volume behavior.
Apr 09 2026 11:04:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals' board will meet to consider the audited financial results for Q4 FY26. The specific date of this meeting will be announced later.
Mar 27 2026 01:03:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals appointed Mr. Aman Purohit as Company Secretary, effective March 25, 2026. He brings 6 years of experience in secretarial compliance, including major assignments like mergers and acquisitions.
Mar 25 2026 19:03:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals board approved the appointment of Mr. Aman Purohit as Company Secretary and Compliance Officer, effective March 25, 2026. He brings 6 years of experience in secretarial compliance.
Mar 25 2026 13:03:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals board approved the appointment of Mr. Aman Purohit as Company Secretary and Compliance Officer, effective March 25, 2026. He brings 6 years of experience in secretarial compliance.
Mar 25 2026 13:03:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals board approved the appointment of Mr. Aman Purohit as Company Secretary and Compliance Officer, effective March 25, 2026. He brings 6 years of experience in secretarial compliance.
Mar 25 2026 13:03:00

BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Balaxi Pharmaceuticals board approved the appointment of Mr. Aman Purohit as Company Secretary and Compliance Officer, effective March 25, 2026. He brings 6 years of experience in secretarial compliance.
Mar 25 2026 13:03:00
Read More

About Balaxi Pharmaceuticals

NSE : 11314  
BSE : 0  
ISIN : INE618N01022  

Balaxi Pharmaceuticals Management

NamePosition
Ashish MaheshwariManaging Director
Minoshi MaheshwariPromoter & Non-Executive Director
View More

Balaxi Pharmaceuticals FAQs

The Buying Price of Balaxi Pharmaceuticals share is 27.46 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Balaxi Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Balaxi Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Balaxi Pharmaceuticals shares is 15.95. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Balaxi Pharmaceuticals shares is 0.63. Useful to assess the stock's value relative to its book value.

To assess Balaxi Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.19 & 2.11 with sector averages, along with growth rates and financial metrics.

The Market Cap of Balaxi Pharmaceuticals is 151.60 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Balaxi Pharmaceuticals share price is 67.19 & 15.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Balaxi Pharmaceuticals belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost